Popular GLP-1 weight-loss drugs linked to lower risks of addiction and overdose
A massive study of more than 600,000 U.S. veterans suggests that popular GLP-1 drugs such as semaglutide may do far more than help with diabetes and weight loss—they could also fight addiction itself. Researchers found that people taking these...
schedule
14:04 visibility
1 views
Source: Science Daily
A massive study of more than 600,000 U.S. veterans suggests that popular GLP-1 drugs such as semaglutide may do far more than help with diabetes and weight loss—they could also fight addiction itself. Researchers found that people taking these medications were less likely to develop substance use disorders involving alcohol, nicotine, cannabis, cocaine, opioids, and other drugs, while those already struggling with addiction experienced fewer overdoses, hospitalizations, emergency visits, and drug-related deaths.
Geoff Keighley’s annual June celebration of games is here. Summer Game Fest Live, the big live show that will feature a whole bunch of gaming news and announcements, begins at 5PM ET and is set to run for two hours. The event itself will take...
The deadly Ebola variant isn't the only thing causing concern for health workers in Congo. Rumors and disinformation are hindering efforts to contain the virus. The patterns are well-known — and could be confronted.
It is not only a deadly Ebola variant causing concern for health workers in DR Congo. Rumors and disinformation hinder efforts to contain the virus. The patterns are well-known — and could be confronted.
Scientists have identified genetic variants that may make some people less responsive to GLP-1 drugs used to treat Type 2 diabetes. Roughly 10% of the population carries these variants, which appear to cause a mysterious form of "GLP-1 resistance."...
In between beef tallow fries, raw milk, and vaccine denialism, Make America Healthy Again figureheads have set their sights on another slice of life: our clothing. "The MAHA movement doesn't stop with what we EAT - It's also about what we WEAR,"...
The Verge
We use cookies to improve your experience. By continuing to use this site, you agree to our use of cookies. Learn more